Please assess the completion status of the following clinical trial:

Trial Title: Effect of Selenium on Succinylcholine-Induced POM

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult Patients aged 20-40 years, either sex.~* ASA physical status I or II.~* Elective sinuscopic procedures.~* Moderate to severe myalgia grade 2,3.~Exclusion Criteria:~* Abnormal renal and liver function tests.~* History of chronic pain, and regular medication with SNRI or analgesics (excluding acetaminophen and nonsteroidal anti-inflammatory drugs).~* patients with a history of seizure disorders, hyperkalemia, systemic illness like hypertension, diabetes, increased intracranial and intraocular pressure, pregnant or breast-feeding females.~* Any patients with previous history of drug induced muscle pain.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Group Placebo (Type: ACTIVE_COMPARATOR): 40 patients will receive starch capsules orally with sips of water 2 hours before induction of anesthesia
- Group Selenium (Type: ACTIVE_COMPARATOR): 40 patients will receive Selenium (selenium NATURE'S BOUNTY, INC. Bohemia) 200 mcg orally with sips of water 2 hours before induction of general anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).